Source document or public record
FDA 510(k) K223078 — Atellica® CH Diazo Direct Bilirubin (D_DBil)
FDA 510(k) index record K223078. Device: Atellica® CH Diazo Direct Bilirubin (D_DBil). Applicant as listed: Siemens Healthcare Diagnostics, Inc.. Decision date: 2023-06-12.
Source
"device_name": "Atellica® CH Diazo Direct Bilirubin (D_DBil)"
This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.
Review and references
Automated FDA record verification
2026-10-20
2026-10-20
professional use
FDA 510(k) public index record K223078.
Device name: Atellica® CH Diazo Direct Bilirubin (D_DBil). Applicant as listed: Siemens Healthcare Diagnostics, Inc..
Decision date: 2023-06-12. Decision wording: Substantially Equivalent.
Product code: CIG. Regulation: 21 CFR 862.1110. Medical specialty: Clinical Chemistry.
This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.